🔎 Trials Near Me

Home › Asthma › Colorado

Pag-aaral pangklinika para sa Asthma sa Colorado

16 pag-aaral para sa Asthma ang naghahanap ng mga kalahok sa mga site sa Colorado.

Mga Lungsod sa Colorado

Opisyal na teksto ng pag-aaral (English)

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

  • Research Site 15, Colorado Springs
Nagre-recruitPhase 3
Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07276724

Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

  • Research Site, Aurora
Nagre-recruitPhase 3
Edad 6 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07444567

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

  • Research Site, Denver
Nagre-recruitPhase 3
Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT06307665

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  • Colorado ENT & Allergy, Colorado Springs
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06977581

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

  • Asthma & Allergy Associates - Colorado Springs, Colorado Springs
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07219173

PULmonary Stimulation for Asthma Relief

  • National Jewish Health, Denver
Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT07709754

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

  • Enveda Investigative Site, Colorado Springs
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07301255

A Study of Depemokimab in Participants of 6 to 11 Years of Age

  • GSK Investigational Site, Colorado Springs
Nagre-recruitPhase 3
Edad 6 hanggang 11 · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT07671001

Registry of Asthma Characterization and Recruitment 3 (RACR3)

  • Children's Hospital Colorado: Allergy Program, Aurora
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Lahat ng edad · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT05272241

A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

  • GSK Investigational Site, Aurora
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07456033

Protocol CAUSE-03 / CHEETAH

  • Children's Hospital Colorado: Allergy Program, Aurora
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Hul 1, 2026 · NCT06136091

Individualizing Treatment for Asthma in Primary Care (Full Study)

  • DARTNet Institute, Aurora
  • University Colorado-Denver, Aurora
Nagre-recruitPhase 4
Edad 13 hanggang 75 · Lahat ng kasarian · Na-update Okt 29, 2025 · NCT07052942

Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma

  • University of Colorado Anschutz Medical Campus, Aurora
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hun 10, 2025 · NCT03762395

Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation

  • National Jewish Health, Denver
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Abr 6, 2023 · NCT05259904

Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics

  • University of Colorado, Aurora
Nagre-recruit
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Peb 2, 2023 · NCT03215836

Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study

  • National Jewish Health, Denver
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2017 · NCT02947945

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.